摘要
目的探讨FBW7与Cullin7在耐紫杉醇三阴乳腺癌组织中的表达。方法免疫组化SP法检测29例耐紫杉醇三阴乳腺癌组织及20例紫杉醇敏感三阴乳腺癌组织中FBW7和Cullin7的表达,分析二者相关性。结果 FBW7在耐紫杉醇三阴乳腺癌组织中阳性表达10例,少于紫杉醇敏感三阴乳腺癌组织的13例(P=0.035)。Cullin7在耐紫杉醇三阴乳腺癌组织中阳性表达18例,多于紫杉醇敏感三阴乳腺癌组织的6例(P=0.047)。FBW7与Cullin7表达在耐紫杉醇三阴乳腺癌中呈正相关(r=0.432,P=0.017)。结论在耐紫杉醇三阴乳腺癌中,FBW7与Cullin7均参与耐药机制发生过程。
引文
[1] Tubtimhin S,Promthet S,Suwanrungruang K,et al.Molecular subtypes and prognostic factors among premenopausal and postmenopausal thai women with invasive breast cancer:15 years follow-up data[J].Asian Pac J Cancer Prev,2018,19(11):3167-3174.
[2] 李俊杰,邵志敏.2018年美国《国家综合癌症网络乳腺癌临床实践指南》解读[J].中华乳腺病杂志(电子版),2018,12(3):129-134.
[3] 中国临床肿瘤学会指南工作委员会.中国临床肿瘤学会(CSCO)乳腺癌诊疗指南[M].北京:人民卫生出版社,2018:41-49.
[4] Walsh EM,Shalaby A,O′Loughlin M,et al.Outcome for triple negative breast cancer in a retrospective cohort with an emphasis on response to platinum-based neoadjuvant therapy[J].Breast Cancer Res Treat,2018,28(5):826-829.
[5] Onishi Y,Eshita Y,Ji RC,et al.Supermolecular drug challenge to overcome drug resistance in cancer cells[J].Drug Discov Today,2018,23(8):1556-1563.
[6] Jemal A,Siegel R,Xu J,et al.Cancer statistics,2010[J].CA Cancer J Clin,2010,60(5):277-300.
[7] Hershko A,Ciechanover A.The ubiquitin system[J].Annu Rev Biochem,1998,67(4):425-429.
[8] Welcker M,Clurman BE.FBW7 ubiquitin ligase:a tumour suppressor at the crossroads of cell division,growth and differentiation[J].Nat Rev Cancer,2008,8(2):83-93.
[9] Enchev RI,Schulman BA,Peter M.Protein neddylation:beyond cullin-RING ligases[J].Nat Rev Mol Cell Biol,2015,16(1):30-44.
[10] Scheufele F,Wolf B,Kruse M,et al.Evidence for a regulatory role of Cullin-RING E3 ubiquitin ligase 7 in insulin signaling[J].Cell Signal,2014,26(2):233-239.
[11] Xi J,Zeng ST,Guo L,et al.High expression of Cullin7 correlates with unfavorable prognosis in epithelial ovarian cancer patients[J].Cancer Invest,2016,34(3):130-136.
[12] Cui SY,Huang JY,Chen YT,et al.Let-7c governs the acquisition of chemo- or radioresistance and epithelial-to-mesenchymal transition phenotypes in docetaxel-resistant lung adenocarcinoma[J].Mol Cancer Res,2013,11(7):699-713.
[13] Wertz IE,Kusam S,Lam C,et al.Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7[J].Nature,2011,471(7336):110-114.
[14] Lau AW,Fukushima H,Wei W.The Fbw7 and betaTRCP E3 ubiquitin ligases and their roles in tumorigenesis[J].Front Biosci(Landmark Ed),2012,17:2197-2212.